References
- Turner EH, Knoepflmacher D, Shapley L. Publication bias in antipsychotic trials: an analysis of efficacy comparing the published literature to the US food and drug administration database. PLoS Med. 2012;9(3):e1001189. Epub 2012 Mar 20.
- Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018 Feb 20;391:1357–1366.
- Goff DC, Hill M, Freudenreich O. Treatment adherence in schizophrenia and schizoaffective disorder. J Clin Psychiatry. 2011 Apr;72(4):e13.
- Sirey JA, Banerjee S, Marino P, et al. Adherence to depression treatment in primary care: a randomized clinical trial. JAMA Psychiatry. 2017 Nov 1;74(11):1129–1135.
- Carta MG, Bhat KM, Preti A. GABAergic neuroactive steroids: a new frontier in bipolar disorders? Behav Brain Funct. 2012;8(1):61.
- Giatti S, Garcia-Segura LM, Barreto GE, et al. Neuroactive steroids, neurosteroidogenesis and sex. Prog Neurobiol. 2018 Jul 4. pii: S0301-0082(18)30008-X. doi: 10.1016/j.pneurobio.2018.06.007. [Epub ahead of print].
- Schverer M, Lanfumey L, Baulieu E, et al. Neurosteroids: non-genomic pathways in neuroplasticity and involvement in neurological diseases. Pharmacol Ther. 2018 Jun 25. pii: S0163-7258(18)30113-X. doi: 10.1016/j.pharmthera.2018.06.011. [Epub ahead of print].
- Gaignard P, Liere P, Thérond P, et al. Role of sex hormones on brain mitochondrial function, with special reference to aging and neurodegenerative diseases. Front Aging Neurosci. 2017;9:406. doi: 10.3389/fnagi.2017.00406.
- Cai H, Cao T, Zhou X, et al. Neurosteroids in schizophrenia: pathogenic and therapeutic implications Front Psychiatry. 2018;9:73.
- Kanes, Stephen, Colquhoun, H., Gunduz-Bruce, H., et al. Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. The Lancet. 2017;390(10093):480–489.
- Gordon, Jennifer L., Rubinow, D. R., Eisenlohr-Moul, T. A, et al. Efficacy of transdermal estradiol and micronized progesterone in the prevention of depressive symptoms in the menopause transition: a randomized clinical trial. JAMA Psychiatry. 2018;75:149.
- Meinhard N, Kessing LV, Vinberg M. The role of estrogen in bipolar disorder, a review. Nord J Psychiatry. 2013;68(2):81–87.
- Talaei A, Pourgholami M, Khatibi-Moghadam H, et al. Tamoxifen: a protein kinase C inhibitor to treat mania: a systematic review and meta-analysis of randomized, placebo-controlled trials. J Clin Psychopharmacol. 2016;36(3):272–275.
- de Boer J, Prikken M, Lei WU, et al. The effect of raloxifene augmentation in men and women with a schizophrenia spectrum disorder: a systematic review and meta-analysis. NPJ Schizophrenia. 2018;4(1):1.